Hypoxic upregulation of arginase II in human lung endothelial cells
about
L-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infantsAloe-emodin suppresses hypoxia-induced retinal angiogenesis via inhibition of HIF-1α/VEGF pathwayFormononetin, an active compound of Astragalus membranaceus (Fisch) Bunge, inhibits hypoxia-induced retinal neovascularization via the HIF-1α/VEGF signaling pathwayReconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration.Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancerArginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice.Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis.Arginase inhibition enhances angiogenesis in endothelial cells exposed to hypoxia.Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction?Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology.Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway.Role of arginase in vessel wall remodeling.Ischemic postconditioning protects the heart against ischemia-reperfusion injury via neuronal nitric oxide synthase in the sarcoplasmic reticulum and mitochondriaBDNF secretion by human pulmonary artery endothelial cells in response to hypoxia.Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?Hypoxic pulmonary vasoconstriction in humansPeroxynitrite and peroxiredoxin in the pathogenesis of experimental amebic liver abscess.Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1α/VEGF Signaling Pathway.Hypoxic Pulmonary Vasoconstriction in Humans: Tale or Myth.Hypoxia-inducible factor-3α promotes angiogenic activity of pulmonary endothelial cells by repressing the expression of the VE-cadherin gene.Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension.Human cytomegalovirus induces upregulation of arginase II: possible implications for vasculopathies.AltitudeOmics: Red Blood Cell Metabolic Adaptation to High Altitude HypoxiaUpregulation of arginase-II contributes to decreased age-related myocardial contractile reserve.A prescribed walking regimen plus arginine supplementation improves function and quality of life for patients with pulmonary arterial hypertension: a pilot study.Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.Pulmonary arterial hypertension in rats due to age-related arginase activation in intermittent hypoxia.Endothelial Cell Metabolism.
P2860
Q26829856-B2585207-0C3D-4444-A45F-9D46A27799FFQ28820904-AB49BE1B-6046-4351-A735-1D80EB1B7201Q28828440-ED71BBE1-36C4-47CE-AE74-8BD5C8ECA474Q33803027-26DAD6EB-3C16-481B-AEF5-83C43E90ED97Q34465434-13064456-022F-4164-8276-152A6A264F4AQ34592559-AAF4336E-14FC-4AD6-9BD6-C4CBE1C0409DQ34730537-3EC64448-5A89-47CF-B052-D2945DE54112Q34752135-74CD0774-A191-4282-8640-B7337C346D65Q35181215-C332586C-DE1C-4549-9B1F-0846DE84933EQ35339312-1EDCC48B-D1C5-42EB-925A-C1685C396161Q35665717-A5802325-1943-44EB-8ACD-8A5D2AD8EF13Q35708220-A220B9BB-81FB-4083-AB66-5CF345B8A0B9Q36837617-36ECD7CF-EC5B-4C79-A0BD-88DBF715BA0CQ37030270-08D0B588-EA9B-4E49-89ED-8DFBFC5C1204Q37688363-AD515B90-CA23-4271-9225-95285E80AE38Q38082329-384B0066-CD4E-4F12-AB63-F78388C764F9Q38136231-F18992DA-8703-4FF9-A931-E2BD2B75D18FQ38211432-D76B90CB-1F6F-4615-BD7C-4C21B3EFE88EQ38724669-7FB23AC0-39D3-4D22-9DF0-7D8B3D1469ECQ39143610-5F9900A9-B240-43B7-8A7C-D238CA637B30Q41519571-0373B7C5-2163-4DD0-B071-119050357B9CQ41572947-5C620D09-3D40-45C0-9AF1-4CC39EA40C10Q42242369-0FDA3863-8293-4B11-998C-93A334DB0E44Q42380761-0FA3BA61-44A1-42AC-B510-D7A2DDFAC33BQ42498817-0389E953-0C94-4E59-AB6C-972E7451EC0EQ47657622-B333D4D7-47E7-49D7-89EF-A6E32B7DB920Q47734746-4EF230F6-D800-4C39-8333-F580FB297948Q48009161-D2713B39-42CE-4B5D-A97F-05128D4701FCQ49787990-67A0639D-3F94-44AC-8986-3B023115BEDE
P2860
Hypoxic upregulation of arginase II in human lung endothelial cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypoxic upregulation of arginase II in human lung endothelial cells
@en
Hypoxic upregulation of arginase II in human lung endothelial cells.
@nl
type
label
Hypoxic upregulation of arginase II in human lung endothelial cells
@en
Hypoxic upregulation of arginase II in human lung endothelial cells.
@nl
prefLabel
Hypoxic upregulation of arginase II in human lung endothelial cells
@en
Hypoxic upregulation of arginase II in human lung endothelial cells.
@nl
P2093
P2860
P1476
Hypoxic upregulation of arginase II in human lung endothelial cells
@en
P2093
Edward R Block
Jawaharlal M Patel
Sergey Zharikov
P2860
P304
P356
10.1152/AJPCELL.00068.2010
P577
2010-09-22T00:00:00Z